Dr Dana Bliuc
Research Level
Biography
Dr Dana Bliuc completed a Masters in Medicine at the University of New South Wales, Australia, in 2004 followed by a PhD from the same university in 2011. Her Masters involved a project aimed to improve the management of osteoporosis following fracture. This project was further extended into an ongoing successful Fracture Liaison Service. Her doctoral studies have focused on determining the total burden of post-fracture outcomes of re-fracture and mortality. Her work on mortality risk post-fracture resulted in several major publications and constituted the basis of an International Consortium of 5 cohorts from Europe and Canada aiming to determine the magnitude and determinants of fracture mortality association.
Following her PhD, Dana was awarded an Early Career NHMRC Fellowship to continue her studies on adverse outcomes following osteoporotic. She played a major role in the analysis of data from multiple large international studies aimed at understanding the burden of adverse events of subsequent fracture and premature mortality following osteoporotic.
Recently, Dana led several pharmaco-epidemiological studies investigating the association between bisphosphonates and mortality risk reduction and identified potential mediators for this association. She currently works on the development of a “whole-population” database which will enable the study of osteoporosis treatment in sick people with multiple co-morbidities, which are currently excluded from previous research.
Dr Dana Bliuc completed a Masters in Medicine at the University of New South Wales, Australia, in 2004 followed by a PhD from the same university in 2011. Her Masters involved a project aimed to improve the management of osteoporosis following fracture. This project was further extended into an ongoing successful Fracture Liaison Service. Her doctoral studies have focused on determining the total burden of post-fracture outcomes of re-fracture and mortality. Her work on mortality risk post-fracture resulted in several major publications and constituted the basis of an International Consortium of 5 cohorts from Europe and Canada aiming to determine the magnitude and determinants of fracture mortality association.
Following her PhD, Dana was awarded an Early Career NHMRC Fellowship to continue her studies on adverse outcomes following osteoporotic. She played a major role in the analysis of data from multiple large international studies aimed at understanding the burden of adverse events of subsequent fracture and premature mortality following osteoporotic.
Recently, Dana led several pharmaco-epidemiological studies investigating the association between bisphosphonates and mortality risk reduction and identified potential mediators for this association. She currently works on the development of a “whole-population” database which will enable the study of osteoporosis treatment in sick people with multiple co-morbidities, which are currently excluded from previous research.
Awards and Honours
2015 Young Investigator International Travel Award, IBMS
2015 Sol Posen Research Award, Australian and New Zealand Bone and Mineral Society
2014/17 NHMRC Early Career Fellowship
2007 Young Investigator Award, American Society for Bone and Mineral Research
2007/09 NHMRC Primary Health Care Scholarship
2006 ANZBMS/IOF Amgen Outstanding Abstract Award
2004 Osteoporosis Australia Scholarship
Education
2005 - MSc (in Medicine), University of New South Wales - Australia
1993 - MD, University of Medicine and Pharmacy, Iasi - Romania
Fundings
Selected, last 5 years
2019 Amgen International Competitive Grant CI Bliuc D. The impact of osteoporosis treatment in the “full-spectrum” of real world patients
2019 St Vincent’s Clinic Foundation AMR Translational Grant CI Center JR, Ghaly S and Bliuc D. Predicting bone loss in patients with inflammatory bowel disease
2018 Aust and NZ Bone and Mineral Society Mid-Career Gap fellowship Bliuc D
2015 International Bone and Mineral Research Society, International Young Investigator Travel Grant. Bliuc D. Osteoporotic Fracture Associated Mortality: A Multinational Study.
2014/17 NH&MRC Early Career Fellowship APP1073430 CI Bliuc D. Causes of Mortality risk following Osteoporotic Fractures
Selected Publications
Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR. Risk of Subsequent Fracture and Mortality in Elderly Women and Men With Fragility Fractures With and Without Osteoporotic Bone Density: The Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 2014 Oct 31
Bliuc D., Nguyen T.V., Eisman J.A. and Center J.R. The impact of non-hip non-vertebral fractures in elderly women and men. J Clin Endocrinol Metab. J Clin Endocrinol Metab. 2014 Feb;99(2):415-23.
Bliuc D., Nguyen N.D., Nguyen T.V., Eisman J.A. and Center J.R. Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res. 2013 Nov;28(11):2317-24
Ahmed LA, Center JR, Bjørnerem A, Bliuc D, Joakimsen RM, Jørgensen L, Meyer HE, Nguyen ND, Nguyen TV, Omsland TK, Størmer J, Tell GS, van Geel TA, Eisman JA, Emaus N. Progressively increasing fracture risk with advancing age after initial incident fragility fracture: the Tromsø study. J Bone Miner Res. 2013 Oct; 28(10):2214-21.
Center JR, Bliuc D, Nguyen ND, Nguyen TV, Eisman JA. Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab. 2011 Apr; 96(4):1006-14.
Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009 Feb 4; 301(5):513-21.
Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007 Jan 24; 297(4):387-94.
Kuo I, Ong C, Simmons L, Bliuc D, Eisman J, Center J. Successful direct intervention for osteoporosis in patients with minimal trauma fractures Osteoporos Int. 2007 Dec;18(12):1633-9.
Bliuc D, Eisman JA, Center JR. A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures Osteoporos Int. 2006; 17(9):1309-17.
Bliuc D, Ong CR, Eisman JA, Center JR Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporos Int. 2005 Aug;16(8):977-82.
